2nd Annual Shaping the Management of Parkinson's Disease
Venue: Vdara Hotel & Spa at CityCenter
Location: Las Vegas, Nevada, United States
Event Date/Time: Feb 08, 2014 / 8:15 am - (PST) | End Date/Time: Feb 09, 2014 / 11:40 am - (PST) |
Early Registration Date: Feb 04, 2014 | Time: 17:00:00 - (PST) |
Description
The “modern clinician” is a practical and caring clinician who
realizes that therapeutic advancements in Parkinson’s disease
are occurring at an unprecedented pace. Much of today’s
treatment approach is based on clinical trial findings. Therefore,
it is important for clinicians to not only be updated with the
clinical trial results, but also to know the hypotheses behind
them, the strengths, weaknesses and other findings outside
the primary objectives of these clinical trials. This educational
program is unique because it intends to discuss the current
approaches to the treatment of Parkinson’s disease in the
context of the “lessons learned” in clinical trials to date. The
program also intends to provide a sneak peak of the future in
PD treatment based on planned and on-going clinical trials for
delaying disease progression and improving motor and nonmotor
symptoms of the disorder.
Venue
Conference Speakers
CoDirectors
Hubert Fernandez, MD
Co-Chair, PSG Executive Committee
Cleveland Clinic
Cleveland, Ohio
Michael Schwarzschild, MD, PhD
Chair, PSG Executive Committee
Harvard Medical School
Boston, Massachusetts
Local Organizing Committee
Eric Farbman, MD
Director of Movement Disorders Center
University of Nevada School of Medicine
Las Vegas, Nevada
Ryan Walsh MD, PhD
Director, Parkinson’s Disease and Movement
Disorders Program
Director, Huntington’s Disease Comprehensive Clinic
Cleveland Clinic Lou Ruvo Center for Brain Health
Las Vegas, Nevada
Faculty
Alberto Espay, MD
Associate Professor of Neurology
Clinical Research Director of the James J. and Joan A. Gardner Center for Parkinson’s Disease and Movement Disorders
University of Cincinnati
Cincinnati, Ohio
Robert Hauser, MD, MBA
Former PSG Executive Committee Member
Professor of Neurology, Molecular Pharmacology and Physiology
Director, USF Byrd Parkinson’s Disease and Movement Disorders Center
University of South Florida
Tampa, Florida
Anthony Lang, OC, MD, FRCPC, FAAN, FCAHS, FRSC Former Chair, PSG Classic Motor Working Group
Movement Disorders Centre
Toronto Western Hospital
Toronto, Ontario, Canada
Peter LeWitt, MD, PhD
Chair, PSG Biomarkers Working Group
Professor of Neurology, Wayne State University School of Medicine
Director, Parkinson's Disease and Movement Disorders Program
Henry Ford West Bloomfield Hospital
Detroit, Michigan
Connie Marras, MD, PhD
Member, PSG Executive Committee
Former Chair, PSG Genetics and Environmental Risk Factors Working Group
Assistant Professor of Neurology
University of Toronto
Toronto, Ontario, Canada.
William Ondo, MD
Professor of Neurology
University of Texas Health Science Center at Houston
Houston Texas
Ronald Pfeiffer, MD
Professor and Vice Chair
Department of Neurology
University of Tennessee Health Science Center
Memphis, Tennessee
Stephen Reich, MD
Professor of Neurology
The Frederick Henry Prince Distinguished Professor in Neurology
Department of Neurology
University of Maryland School of Medicine
Baltimore, Maryland
Tanya Simuni, MD
Chair, PSG Classic Motor Working Group
Arthur C. Nielsen Professor of Neurology
Director, Parkinson's Disease and Movement Disorders Center
Northwestern University Feinberg School of Medicine
Chicago, Illinois
Michele Tagliati, MD, FAAN
Vice Chairman, Department of Neurology
Director of Movement Disorders
Cedars-Sinai Medical Center
Los Angeles, California
Caroline Tanner, MD, PhD, FAAN
Former Co-Chair, PSG Executive Committee
Director, Clinical Research
Parkinson’s Institute
Sunnyvale, California
Daniel Weintraub, MD
Member, PSG Executive Committee
Associate Professor of Psychiatry and Neurology
Perelman School of Medicine
University of Pennsylvania
Philadelphia, Pennsylvania
Additional Information
Learning Objective
After completing this activity, the participant will be able to do
the following:
• List the current and emerging treatment approaches for the
newly diagnosed Parkinson’s disease (PD) patient
• Describe the current and future treatment options for motor
complications in PD
• Recognize and treat the most common nonmotor problems
associated with PD
• Explain the role of deep brain stimulation (DBS) surgery and
other advanced therapies for PD
• Analyze the strengths and weaknesses of clinical trials
and their contribution to today’s evidence-based treatment
approach to PD
Fee includes: Syllabus, continental breakfasts, refreshment breaks, and Saturday lunch.
PSG Member
Investigator $100
Coordinator $50
PSG Member Non PSG Member
Physician $200
Resident/Fellow* $50
Non-Physician $100
*Letter from program director must be received in our office prior to the course to receive this fee.
All memberships will be verified before the meeting.
Exhibits included
Exhibitor Package – Two Day Exhibit $2,500
Includes: Two day exhibit Saturday & Sunday Feb. 8th & 9th, 2014 One 6' Table, 2 chairs, linen and skirting Two Exhibitor badges (provides admission to education program) Complimentary breakfast, lunch and refreshments (available with Exhibitor Badge) Exhibit Location: Assigned Syllabus Roster of Attendees (Name, City, State)
Exhibitor Package – One Day Exhibit $2,000
Includes: One day exhibit Saturday Feb. 8th only, 2014 One 6' Table, 2 chairs, linen and skirting Two Exhibitor badges (provides admission to education program) Complimentary breakfast, lunch and refreshments (available with Exhibitor Badge) Exhibit Location: Assigned Syllabus Roster of Attendees (Name, City, State)
Exhibitor Package – One Day Exhibit $1,000
Includes: One day exhibit Sunday Feb. 9th, 2014 One 6' Table, 2 chairs, linen and skirting Two Exhibitor badges (provides admission to education program) Complimentary breakfast, lunch and refreshments (available with Exhibitor Badge) Exhibit Location: Assigned Syllabus Roster of Attendees (Name, City, State)